Catalog Number 519650 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Erosion (1750); Micturition Urgency (1871); Incontinence (1928); Itching Sensation (1943); Pain (1994); Urinary Tract Infection (2120); Urinary Frequency (2275); Abdominal Cramps (2543); Dysuria (2684); Genital Bleeding (4507)
|
Event Date 09/02/2021 |
Event Type
Injury
|
Event Description
|
As reported to coloplast, though not verified, legal representative stated the patient with this device experienced recurrent erosion and device exposure along the anterior vaginal wall.The patient had an exam, hysteroscopy with endometrial sling sampling, and focal excision of midurethral device under general anesthesia.The patient had an exam, robotic assisted laparoscopic hysterectomy, bilateral salpingectomy, cystoscopy and revision of midurethral device under general anesthesia.
|
|
Manufacturer Narrative
|
Coloplast has not been provided any corroborating evidence to verify the information contained in this report.Without the benefit of examination and testing, coloplast is precluded from commenting on the condition of the device or the cause of the occurrence.Should additional facts prompt us to alter or supplement any information or conclusions contained in the original mdr or in any prior supplemental reports, a follow-up report will be submitted.
|
|
Manufacturer Narrative
|
This complaint was investigated to the extent information was provided to coloplast.Due to the legal nature of this complaint and the device not being returned for evaluation a thorough investigation could not be executed.Should additional information become available, this file will be re-evaluated and updated according to current procedures.Complaints of this nature are monitored and captured within the product risk documentation.No further action or corrective action is required at this time.
|
|
Event Description
|
Additional information received on (b)(6) 2023 indicates that the patient is experiencing recurrent urinary tract infections, urinary frequency and urgency, pain, vaginal bleeding, dysuria, itchiness, incontinence, and abdominal cramping.
|
|
Manufacturer Narrative
|
Portions of this event were previously reported under mfg report number 2125050-2023-01214 & 2125050-2023-01031 & 2125050-2023-01028.Any additional information received regarding this event will be reported under this mfg report number 2125050-2023-00863.
|
|
Search Alerts/Recalls
|